On extending our analysis to other bone and soft tissue tumors we have shown that there is a clear trend for higher levels of ctDNA in patients with higher‐grade disease.
← all excerpts
Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection.
1
—
—